Responses
Systematic review/Meta-analyses
Biomarkers for the diagnosis of Alzheimer’s disease, dementia Lewy body, frontotemporal dementia and vascular dementia
Compose a Response to This Article
Other responses
Jump to comment:
- Published on: 1 April 2019
- Published on: 1 April 2019Is it really worth it?
Currently there is no cure for dementia. Dementia as we know is largely a clinical diagnosis. Unless of course we are looking at more rarer dementia differential for example CJD, autoimmune encephalopathy etc, putting elderly patients through further testing for CSF when clinically diagnosis seems probable, is not going to change future management plan and it is often distressing for patients and their carers. Although this is not by any way to challenge the utility of biomarker testing, but where we stand now is that dementia is progressive Neuro degenerative condition and what family and carer expectations are that of more person centres and holistic approach in providing that care and support.
Conflict of Interest:
None declared.